Aging
Conditions
Interventions
Investigational Product Group:Ergothioneine (EGT)
Sponsors
The First People's Hospital of Kunshan
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 35–70 years, male or female; 2. Signed informed consent form.
Exclusion criteria
Exclusion criteria: 1. Individuals with any immunodeficiency disease or condition; 2. Pregnant or lactating women, or those planning pregnancy during the trial period; 3. Individuals with severe cardiac, hepatic, or renal insufficiency, malignant tumors, mental illness, or cognitive impairment; 4. Known or suspected allergy to the investigational product or its excipients; 5. Poor compliance judged by the investigator, or any other condition that the investigator deems unsuitable for participation in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Superoxide Dismutase;Glutathione Peroxidase;Malondialdehyde; | — |
Secondary
| Measure | Time frame |
|---|---|
| Grip Strength;Skeletal Muscle Mass;Urea;Alanine Aminotransferase;Creatinine;8-hydroxy-2'-deoxyguanosine;Facial Skin Wrinkles;Facial Skin Redness;Pittsburgh Sleep Quality Index;Serum Uric Acid;Secretory Immunoglobulin A;CD3+;Interleukin-6;Quality of Life Questionnaire;Aspartate Aminotransferase;CD4+;Tumor Necrosis Factor-a;CD8+;Total Antioxidant Capacity; | — |
Countries
China
Contacts
Public ContactChen Yafang
The First People's Hospital of Kunshan
Outcome results
None listed